Use of Therapeutic Hypothermia Associated With Reduced Risk of Survival After In-Hospital Cardiac Arrest
Therapeutic hypothermia, or targeted temperature management, is recommended for comatose patients following both out-of-hospital and in-hospital cardiac arrest. Nevertheless, therapeutic hypothermia has only been shown to improve overall survival and rates of favourable neurological survival in patients with out-of-hospital cardiac arrest due to ventricular fibrillation. Whether this treatment improves survival for patients with in-hospital cardiac arrest is unknown.
As in-hospital cardiac arrest affects approximately 200,000 individuals annually in the United States, there is a need to understand whether therapeutic hypothermia is associated with improved survival for these patients.
Paul S. Chan, MD, Saint Luke’s Mid America Heart Institute, Kansas City, Kansas, and colleagues evaluated the association of hypothermia treatment with survival to hospital discharge and with favourable neurological survival at hospital discharge among patients with in-hospital cardiac arrest.
With the use of the national Get With the Guidelines-Resuscitation registry, the researchers identified 26,183 patients successfully resuscitated from an in-hospital cardiac arrest between March 2002 and December 2014, and either treated or not treated with hypothermia at 355 US hospitals.
Overall, 1,568 of 26,183 patients with in-hospital cardiac arrest (6%) were treated with therapeutic hypothermia; 1,524 of these patients were matched to 3,714 non-hypothermia-treated patients. After adjustment, therapeutic hypothermia was associated with lower in-hospital survival (27.4% vs 29.2%), and this association was similar for nonshockable cardiac arrest rhythms (22.2% vs 24.5%) and shockable cardiac arrest rhythms (41.3% vs 44.1%).
Therapeutic hypothermia was also associated with lower rates of favourable neurological survival for the overall study group (hypothermia-treated group, 17%; non-hypothermia-treated group, 20.5%) and for both rhythm types.
When follow-up was extended to 1 year, there remained no survival advantage with therapeutic hypothermia treatment.
“These observational findings warrant a randomised clinical trial to assess efficacy of therapeutic hypothermia for in-hospital cardiac arrest.”
DG News saves you time by delivering a short list of medical developments worthy of your time and attention. Our advanced algorithms rank clinical content based on hundreds of data points to surface the most important medical advances impacting your practice each week.